Methodological items for non-randomized studies (MINORS). by Solima Sabeel (9545738)

Jadad Score of randomized controlled trials. by Solima Sabeel (9545738)

Association Between App Feasibility and Quality of Life and 30-Day Hospital Readmission. by Sandra M. Ragheb (12975445)

Version 2 of the Cochrane risk-of-bias tool for randomized controlled trials. by Solima Sabeel (9545738)

Analysis of randomized controlled trials stratified based on treatment duration. by Solima Sabeel (9545738)

PRISMA flow diagram of the systematic literature search process. by Solima Sabeel (9545738)

Relation between neurite curvature and age. by Ryuta Mizutani (4512997)

“…Quartiles are indicated with bars. Curvature maximum decreases with age, resulting in a decrease in the distribution span due to aging. …”

Excluded skewed studies. by Solima Sabeel (9545738)

Fig 2 - by Natália de Souza Duarte (18264611)

Summary of randomized controlled trials. by Solima Sabeel (9545738)

Summary of non-randomized studies. by Solima Sabeel (9545738)

Post-Discharge MHealth Participant Satisfaction Responses by Age Category. Categorical variables expressed as n (%). Percentages include participants who Agreed or Strongly Agreed... by Sandra M. Ragheb (12975445)

Cox hazard regression model of renalase and primary composite outcome. by Basmah Safdar (12213257)

Summary table showing analysis of randomized controlled trials stratified based on age groups. by Solima Sabeel (9545738)

Details of statistical analyses applied related to Figs 3, S3, and S4. by Eudald Pascual-Carreras (12115380)

Forest plot showing the SMD (Standardized mean difference) and 95% CI for External rotation after surgery with and without the study by Zwaal¹³ during a sensitivity anal... by Liancheng Shan (551063)

Forest plot showing the SMD (Standardized mean difference) and 95% CI for Forward flextion after surgery with and without the study by Zwaal¹³ during a sensitivity analy... by Liancheng Shan (551063)

Fig 1 - by Yiu-Chung Lau (18713218)

Table_3_Mutations identified in engineered Escherichia coli with a reduced genome.XLSX by Yuto Kotaka (15907688)

“…The first was an insertion at the promoter region of pntA, which increased cognate gene expression. The second was an insertion sequence (IS) present in sibE, encoding the antitoxin in a toxin-antitoxin system, which decreased expression of sibE. 5 strains of Δ37c independently isolated following ALE harboring multiple SNVs and genetic rearrangements. …”

Table_2_Mutations identified in engineered Escherichia coli with a reduced genome.XLSX by Yuto Kotaka (15907688)

“…The first was an insertion at the promoter region of pntA, which increased cognate gene expression. The second was an insertion sequence (IS) present in sibE, encoding the antitoxin in a toxin-antitoxin system, which decreased expression of sibE. 5 strains of Δ37c independently isolated following ALE harboring multiple SNVs and genetic rearrangements. …”